Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
05/2003
05/22/2003US20030096374 Synthesis of oligoketides
05/22/2003US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc.
05/22/2003CA2724716A1 Process for preparation of .alpha.-hydroxycarboxylic acid amides
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003CA2464863A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312607A1 Dithiocarbamate derivatives and their use as antibacterial agents
05/21/2003EP1312606A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres
05/21/2003EP1312605A1 Method for producing biaryl compounds
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311484A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311483A2 Process for the preparation of 2-aminomethylpyridines
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311477A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
05/21/2003EP1311476A1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311473A2 Novel compounds inhibiting factor xa activity
05/21/2003EP1311265A2 Pharmaceutical compositions for treating neurological disorders
05/21/2003EP1283711A4 Peptide deformylase inhibitors
05/21/2003EP0820285B1 Methods and compositions for lipidization of hydrophilic molecules
05/21/2003CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403
05/21/2003CN1419537A Insecticidal anthranilamides
05/21/2003CN1418874A pH sensitive carrier isonicatinic didecyl amine and formed high molecule film pH electrode
05/21/2003CN1418873A Process for synthesizing 3-12,5,6-trialogenated pyridine-3-group) ethyl 3-oxopropanoate from 2,5,6-trialogenated-3-cyanopyridine
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
05/20/2003US6566550 Substituted aromatic ethers as inhibitors of glycine transport
05/20/2003US6566547 Fungicides
05/20/2003US6566527 Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-methylsulphonyl)-phenyl]ethanone
05/20/2003US6566518 Trifluoromethylpyri(mi)dine carboxamides
05/20/2003US6566510 Morphine-6-glucuronide synthesis
05/20/2003US6566462 Multiple catalyst system
05/20/2003US6566409 Lock and key micelles
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566380 For therapy of cardiac arrhythmias
05/20/2003US6566379 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
05/20/2003US6566340 Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
05/20/2003US6566034 Photographic material containing a novel hydrazine type
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003US6565769 Electrooptical liquid crystal system
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2117059C Pyrido-pyridazinone and pyridazinthione compounds
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040257A1 Electroluminescent platinum compounds and devices made with such compounds
05/15/2003WO2003040160A1 Rhodium and iridium complexes
05/15/2003WO2003040149A2 Asymmetric catalysis based on chiral phospholanes and hydroxyl phospholanes
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040102A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors
05/15/2003WO2003040101A1 Anthranilic acid amides and pharmaceutical use thereof
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003039552A1 Combination of pde4 or pde3/4 inhibitor and an anti-rheumatic drug
05/15/2003WO2003039549A2 Selective antibacterial agents
05/15/2003WO2003039535A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
05/15/2003WO2003039454A2 Beta-secretase inhibitors and methods of use
05/15/2003WO2003039446A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
05/15/2003WO2001079173A3 Enamine derivatives as cell adhesion molecules
05/15/2003US20030092915 Using phase transfer catalyst and quaternary ammonium compound
05/15/2003US20030092914 Process for preparing alkanesulfonyl pyridines
05/15/2003US20030092910 Piperazine derivatives and process for the preparation thereof
05/15/2003US20030092747 Secretase inhibitor
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092743 Viricides; aids therapy
05/15/2003US20030092739 Pesticides
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092709 6-Methylnicotinamide derivatives as antiviral agents
05/15/2003US20030092708 Anticholesterol agents; cardiovascular disorders; antilipemic agents
05/15/2003US20030092706 Mixtures of phosphodiesterase inhibitor and antiarthritic agents; bioavailability, side effect reduction
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092679 Novel non-convalent thrombin inhibitors
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092140 Novel polyketides and antibiotics
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2466119A1 Electroluminescent platinum compounds and devices made with such compounds
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003CA2464757A1 Selective antibacterial agents
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/15/2003CA2462158A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
05/14/2003EP1310540A1 Polymer electroluminescent device
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309558A1 Aspartate derivative of amlodipine as calcium channel antagonist
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003EP1248618A4 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl
05/14/2003EP1240162B1 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same
05/14/2003EP1140905B1 Heteroaromatic amides as inhibitor of factor xa
05/14/2003EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation
05/14/2003EP0946550A4 PREPARATION OF 1S- 1a,2b,3b,4a(S*)]]-4- 7- 1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO 4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
1 ... 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 ... 633